<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39449696</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>30</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Identification of JC polyomavirus in upper respiratory samples from Portuguese children.</ArticleTitle><Pagination><StartPage>e38996</StartPage><MedlinePgn>e38996</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38996</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e38996</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">JC polyomavirus (JCPyV) is ubiquitous in the human population and the causative agent of a rare, fatal and demyelinating disease of the central nervous system named Progressive Multifocal Leukoencephalopathy (PML). The route of JCPyV transmission remains unclear, but high values of seroprevalence suggest an easy and frequent mode, such as respiratory route.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">The present study aims to investigate the presence of JCPyV in upper respiratory samples and contribute to the elucidation of the JCPyV transmission pathway.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="UNASSIGNED">Nasopharyngeal swabs from 587 Portuguese individuals, including 380 children (≤18 years) and 207 adults (&gt;18 years), collected for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis between September and November 2021 were evaluated for the presence of JCPyV DNA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">JCPyV DNA was detected in 3.1 % of the nasopharyngeal swabs analysed, with higher frequency of detection in samples from children (4.5 %) than from adults (0.5 %) (<i>p</i> = 0.005). Infection with SARS-CoV-2 does not potentiate the presence of JCPyV in upper respiratory tract, once only one adult of 28 years with confirmed SARS-CoV-2 infection showed detectable JCPyV DNA. JCPyV DNA was more frequently detected in respiratory samples from children without SARS-CoV-2 infection (6.4 %). As for this group, children under six years of age presents the highest frequency of detection (10.3 %).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The present study demonstrates that upper respiratory secretions of children, particularly under the age of six, may be implicated in JCPyV transmission, regardless of SARS-CoV-2 infection.</AbstractText><CopyrightInformation>© 2024 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Joana M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>University of Coimbra, CERES, Faculty of Pharmacy, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Functional Ecology (CFE), Associate Laboratory TERRA, Department of Life Sciences, University of Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Microbiology, Faculty of Pharmacy, University of Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veiga</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Analysis from University of Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Faculty of Pharmacy, University of Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luxo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Coimbra, CERES, Faculty of Pharmacy, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Microbiology, Faculty of Pharmacy, University of Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matos</LastName><ForeName>Ana M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>University of Coimbra, CERES, Faculty of Pharmacy, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Microbiology, Faculty of Pharmacy, University of Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Clinical Analysis from University of Coimbra, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">JC polyomavirus</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Transmission</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39449696</ArticleId><ArticleId IdType="pmc">PMC11497384</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e38996</ArticleId><ArticleId IdType="pii">S2405-8440(24)15027-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kato A., Kitamura T., Takasaka T., Tominaga T., Ishikawa A., Zheng H.Y., Yogo Y. Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy. J. Neurovirol. 2004;10:244–249. doi: 10.1080/13550280490468663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280490468663</ArticleId><ArticleId IdType="pubmed">15371154</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.K., Gordon J., Khalili K. The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog. 2013;9 doi: 10.1371/journal.ppat.1003206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003206</ArticleId><ArticleId IdType="pmc">PMC3597531</ArticleId><ArticleId IdType="pubmed">23516356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang N.V., Xuan N.T., Trung N.D., Thu N.T., Nam N.Q., Hai V.A., Hang D.T.T., Quyen L.T.B., Thuong L.T.H., Lam N.Q., Thong N.H., Phuong N.M., Linh N.T., Tu H.V., Cuong L.M., Su H.X. Prevalence and genotype distribution of JC polyomavirus in urine from patients with hematological malignancies in Vietnam. J. Med. Virol. 2021;93:5193–5198. doi: 10.1002/jmv.27078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27078</ArticleId><ArticleId IdType="pubmed">33974279</ArticleId></ArticleIdList></Reference><Reference><Citation>Matos A., Duque V., Beato S., Da Silva J.P., Major E., Meliço-Silvestre A. Characterization of JC human polyomavirus infection in a Portuguese population. J. Med. Virol. 2010;82:494–504. doi: 10.1002/jmv.21710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21710</ArticleId><ArticleId IdType="pubmed">20087944</ArticleId></ArticleIdList></Reference><Reference><Citation>Nali L.H., Centrone de C.C., Urbano P.R., Penalva-de-Oliveira A.C., Vidal J.E., Miranda E.P., Pannuti C.S., Fink M.C. High prevalence of the simultaneous excretion of polyomaviruses JC and BK in the urine of HIV-infected patients without neurological symptoms in São Paulo, Brazil. Rev. Inst. Med. Trop. Sao Paulo 54 (4) (2012 ) 201–205, doi: 10.1590/s0036-46652012000400004. PMID: 22850991.</Citation><ArticleIdList><ArticleId IdType="pubmed">22850991</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson A.L., Atwood W.J. Fifty years of JC polyomavirus: a brief overview and remaining questions. Viruses. 2020;12:969. doi: 10.3390/v12090969.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12090969</ArticleId><ArticleId IdType="pmc">PMC7552028</ArticleId><ArticleId IdType="pubmed">32882975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellizzi A., Anzivino E., Rodio D.M., Palamara A.T., Nencioni L., Pietropaolo V. New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy. Clin. Dev. Immunol. 2013;2013:1–17. doi: 10.1155/2013/839719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/839719</ArticleId><ArticleId IdType="pmc">PMC3652120</ArticleId><ArticleId IdType="pubmed">23690827</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaolo V., Prezioso C., Bagnato F., Antonelli G. John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy. New Microbiol. 2018;41:179–186.</Citation><ArticleIdList><ArticleId IdType="pubmed">29620790</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook L. Polyomaviruses. Microbiol. Spectr. 2016;4 doi: 10.1128/microbiolspec.DMIH2-0010-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.DMIH2-0010-2015</ArticleId><ArticleId IdType="pubmed">27726799</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia F., Villani S., Ambrogi F., Signorini L., Dallari S., Binda S., Primache V., Pellegrinelli L., Ferrante P., Delbue S. JC virus infection is acquired very early in life: evidence from a longitudinal serological study. J. Neurovirol. 2017;23:99–105. doi: 10.1007/s13365-016-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-016-0477-9</ArticleId><ArticleId IdType="pubmed">27538993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sá M., Nunes C.C., da Silva A.M., Mota P., Pinto-Marques J. JC virus antibodies in Portuguese multiple sclerosis patients: JUSTIFY study results. J. Neurol. Sci. 2019;406 doi: 10.1016/j.jns.2019.116426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.116426</ArticleId><ArticleId IdType="pubmed">31629287</ArticleId></ArticleIdList></Reference><Reference><Citation>Aladro Y., Terrero R., Cerezo M., Ginestal R., Ayuso L., Meca-Lallana V., Millán J., Borrego L., Martinez-Ginés M., Rubio L., De Andrés C., Miralles A., Guijarro C., Rodríguez-García E., García-Dominguez J.M., Muñoz-Fernández C., López De Silanes C., Gómez M., Thuissard I., Cerdán M., Palmí I., Díaz-Garzón L.F., Meca-Lallana J. Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort JC virus seroprevalence in Spain. J. Neurol. Sci. 2016;365:16–21. doi: 10.1016/j.jns.2016.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.03.050</ArticleId><ArticleId IdType="pubmed">27206867</ArticleId></ArticleIdList></Reference><Reference><Citation>Viscidi R.P., Rollison D.E., Sondak V.K., Silver B., Messina J.L., Giuliano A.R., Fulp W., Ajidahun A., Rivanera D. Age-specific seroprevalence of merkel cell polyomavirus, BK virus, and JC virus. Clin. Vaccine Immunol. 2011;18:1737–1743. doi: 10.1128/CVI.05175-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.05175-11</ArticleId><ArticleId IdType="pmc">PMC3187023</ArticleId><ArticleId IdType="pubmed">21880855</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine H.K., Waterboer T., Syrjänen K., Grenman S., Louvanto K., Syrjänen S. Seroprevalence of polyomaviruses BK and JC in Finnish women and their spouses followed-up for three years. Sci. Rep. 2023;13 doi: 10.1038/s41598-023-27850-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-27850-7</ArticleId><ArticleId IdType="pmc">PMC9845201</ArticleId><ArticleId IdType="pubmed">36650213</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles W.A. vol. 2. 2006. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV) (Polyomaviruses and Human Diseases). Chapter.</Citation><ArticleIdList><ArticleId IdType="pubmed">16626025</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilibic-Cavlek T., Bogdanic M., Peric T., Radmanic L., Antolasic L., Milasincic L., Zidovec-Lepej S. Prevalence of JC polyomavirus in patients with neuroinvasive disease of unknown etiology in Croatia. Medicina (Lithuania) 2024;60 doi: 10.3390/medicina60010069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina60010069</ArticleId><ArticleId IdType="pmc">PMC10820756</ArticleId><ArticleId IdType="pubmed">38256330</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonsson A., Green A.C., Mallitt K.-A., O'Rourke P.K., Pawlita M., Waterboer T., Neale R.E. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J. Gen. Virol. 2010;91:1849–1853. doi: 10.1099/vir.0.020115-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.020115-0</ArticleId><ArticleId IdType="pubmed">20219899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009;5 doi: 10.1371/journal.ppat.1000363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000363</ArticleId><ArticleId IdType="pmc">PMC2655709</ArticleId><ArticleId IdType="pubmed">19325891</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain I., Tasneem F., Umer M., Pervaiz A., Raza M., Arshad M.I., Shahzad N. Specific and quantitative detection of Human polyomaviruses BKPyV and JCPyV in the healthy Pakistani population. Virol. J. 2017;14 doi: 10.1186/s12985-017-0752-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0752-2</ArticleId><ArticleId IdType="pmc">PMC5404684</ArticleId><ArticleId IdType="pubmed">28438210</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A., Sariyer I.K., Berger J.R. Revisiting JC virus and progressive multifocal leukoencephalopathy. J. Neurovirol. 2023;29:524–537. doi: 10.1007/s13365-023-01164-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-023-01164-w</ArticleId><ArticleId IdType="pubmed">37659983</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger J.R., Miller C.S., Mootoor Y., Avdiushko S.A., Kryscio R.J., Zhu H. JC virus detection in bodily fluids: clues to transmission. Clin. Infect. Dis. 2006;43:e9–e12. doi: 10.1086/504947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/504947</ArticleId><ArticleId IdType="pubmed">16758410</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro T., Fink M.C.D., Figueiredo M., Braz-Silva P.H., Pannuti C.M., Ortega K.L., Gallottini M. Polyomavirus BK and JC in individuals with chronic kidney failure, kidney transplantation, and healthy controls. J. Clin. Virol. 2017;89:5–9. doi: 10.1016/j.jcv.2017.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.02.003</ArticleId><ArticleId IdType="pubmed">28189092</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo M.A., Domingues Fink M.C., Castro T., Braz-Silva P.H., Steffens J.C., Eduardo F.P., Gallottini M., Ortega K.L. Detection of human polyomaviruses JC and BK in liver pretransplant patients. Oral Dis. 2017;23:1127–1133. doi: 10.1111/odi.12707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.12707</ArticleId><ArticleId IdType="pubmed">28650084</ArticleId></ArticleIdList></Reference><Reference><Citation>Matos A., Duque V., Luxo C., Meliço-Silvestre A., Major E.O. Individuals infected with JC polyomavirus do not present detectable JC virus DNA in oropharyngeal fluids. J. Gen. Virol. 2012;93:692–697. doi: 10.1099/vir.0.036798-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.036798-0</ArticleId><ArticleId IdType="pmc">PMC7346603</ArticleId><ArticleId IdType="pubmed">22158878</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena G.P.A., Mendes G.S., Dias H.G., Gavazzoni L.S., Amorim A.R., Santos N., Human polyomavirus K.I., Wu B.K. JC in healthy volunteers. Eur. J. Clin. Microbiol. Infect. Dis. 2019;38:135–139. doi: 10.1007/s10096-018-3404-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-3404-6</ArticleId><ArticleId IdType="pubmed">30338464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggiero F., Carbone D., Mugavero R., Palmieri A., Lauritano D., Baggi L., Nardone M., Martinelli M., Carinci F. Human polyomavirus in tonsillar microbiota of an Afghan population group. J. Biol. Regul. Homeost. Agents. 2018;32:185–190.</Citation><ArticleIdList><ArticleId IdType="pubmed">29460539</ArticleId></ArticleIdList></Reference><Reference><Citation>Airlangga E., Wahyuni A.S., Siregar J., Malisie R.F., Lubis B.M., Adisasmito W.B., Zarlis M., Pasaribu A.P. Determinants of COVID-19 severity and mortality in children: a retrospective and multicenter cohort study in Medan, Indonesia. Narra J. 2024;4:e865. doi: 10.52225/narra.v4i2.865.</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narra.v4i2.865</ArticleId><ArticleId IdType="pmc">PMC11391977</ArticleId><ArticleId IdType="pubmed">39280281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryschkewitsch C., Jensen P., Hou J., Fahle G., Fischer S., Major E.O. Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid. J Virol Methods. 2004;121:217–221. doi: 10.1016/j.jviromet.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2004.06.021</ArticleId><ArticleId IdType="pubmed">15381359</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco C., Jensen P.N., Hou J., Durham L.C., Major E.O. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J. Virol. 1998;72:9918–9923. https://journals.asm.org/journal/jvi</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110504</ArticleId><ArticleId IdType="pubmed">9811728</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiara M., Monaco G., Atwood W.J., Gravell Maneth, Tornatore C.S., Major E.O. JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J. Virol. 1996;70:7004–7012. https://journals.asm.org/journal/jvi</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190751</ArticleId><ArticleId IdType="pubmed">8794345</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung N.H.L. Transmissibility and transmission of respiratory viruses. Nat. Rev. Microbiol. 2021;19:528–545. doi: 10.1038/s41579-021-00535-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00535-6</ArticleId><ArticleId IdType="pmc">PMC7982882</ArticleId><ArticleId IdType="pubmed">33753932</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheit T., Dutta S., Oliver J., Robitaille A., Hampras S., Combes J.D., McKay-Chopin S., Le Calvez-Kelm F., Fenske N., Cherpelis B., Giuliano A.R., Franceschi S., McKay J., Rollison D.E., Tommasino M. Isolation and characterization of a novel putative human polyomavirus. Virology. 2017;506:45–54. doi: 10.1016/j.virol.2017.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.03.007</ArticleId><ArticleId IdType="pmc">PMC9265179</ArticleId><ArticleId IdType="pubmed">28342387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wollebo H.S., White M.K., Gordon J., Berger J.R., Khalili K. Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann. Neurol. 2015;77:560–570. doi: 10.1002/ana.24371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24371</ArticleId><ArticleId IdType="pmc">PMC4376594</ArticleId><ArticleId IdType="pubmed">25623836</ArticleId></ArticleIdList></Reference><Reference><Citation>Prezioso C., Moens U., Oliveto G., Brazzini G., Piacentini F., Frasca F., Viscido A., Scordio M., Guerrizio G., Rodio D.M., Pierangeli A., D’ettorre G., Turriziani O., Antonelli G., Scagnolari C., Pietropaolo V. Ki and Wu polyomavirus in respiratory samples of sars‐cov‐2 infected patients. Microorganisms. 2021;9:1259. doi: 10.3390/microorganisms9061259.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061259</ArticleId><ArticleId IdType="pmc">PMC8229673</ArticleId><ArticleId IdType="pubmed">34207902</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigiser I., Piura Y., Kolb H., Shiner T., Komarov I., Karni A., Regev K. JCV seroconversion rate during the SARS COVID-19 pandemic. Mult Scler Relat Disord. 2022;68 doi: 10.1016/j.msard.2022.104244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2022.104244</ArticleId><ArticleId IdType="pmc">PMC9598043</ArticleId><ArticleId IdType="pubmed">36544311</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>